For laboratory research use only. Not for human or veterinary use. Read our research-use policy

Short peptides

Vesugen research peptide

Vesugen is the name used in the Khavinson-group literature for a vasoprotective short peptide, reported there as the tripeptide Lys-Glu-Asp (KED).

2 sizes · from $20.99 · 1 in stock · flat $24.95 US shipping per order

Sizes, prices and availability

Vesugen sizes and prices
SizeSKUStated purityBatch COAPriceAvailability
10 mg VE10 Not yet provided Not yet provided $21.99 Out of stock
20 mg VE20 Not yet provided Not yet provided $20.99 In stock

Prices and stock are checked at build time and refreshed live in your browser. Orders are US only for a flat $24.95 shipping fee. Shipping details

About Vesugen

Vesugen is the name the Khavinson research group uses for a short vasoprotective peptide that the same group describes as the tripeptide Lys-Glu-Asp (KED). Khavinson et al. (2014) report that vesugen stimulated the proliferation marker Ki-67, which had decreased with ageing, in tissue-specific cell cultures from young and old animals and in dissociated vascular endothelial cell cultures, and that molecular docking placed it at the promoter region of the MKI67 gene.

Kozlov et al. (2016) report that the KED peptide normalised endothelin-1 expression in in-vitro models of atherosclerotic and restenotic endothelium, restored connexin expression and increased sirtuin 1 expression. Chalisova et al. (2012) report that Lys-Glu-Asp stimulated proliferation and inhibited apoptosis in organotypic cultures of neuroimmunoendocrine cells, and Khavinson et al. (2021) review its effect on gene expression in neurogenesis models. The work is largely from one group, much of it in Russian-language journals.

What the published literature covers

  • Khavinson et al. (2014) examine vesugen and endothelial cell proliferation during ageing, including docking to the MKI67 promoter.
  • Kozlov et al. (2016) examine KED in normal, atherosclerotic and restenotic endothelium in vitro.
  • Chalisova et al. (2012) report effects of Lys-Glu-Asp on neuroimmunoendocrine cell cultures.
  • Khavinson et al. (2021) review KED and gene expression in neurogenesis models.

Vial arithmetic

The peptide reconstitution calculator converts a vial size, diluent volume and target amount into concentration, syringe units and draws per vial. Volumes convert to syringe units with the syringe units converter. It does arithmetic only and does not suggest any amount.

FAQ

What is vesugen?

A short peptide used in the Khavinson-group literature, described there as the tripeptide Lys-Glu-Asp (KED). PubChem lists lysyl-glutamyl-aspartic acid as C15H26N4O8, 390.39 g/mol.

What does the literature consist of?

In-vitro cell and tissue-culture studies and reviews, mostly from one research group and much of it in Russian-language journals.

How is identity checked?

By mass spectrometry: the monoisotopic [M+H]+ is expected near m/z 391.18. For so small a peptide also compare retention with a standard.

What sizes of Vesugen does Covalume list?

Covalume lists Vesugen in 2 sizes: 10 mg, 20 mg. Each size shows its price and live stock status in the variants table on this page.

How is the purity of Vesugen documented?

Each listing shows the purity the supplier states, labelled (supplier), and the batch Certificate of Analysis field reads "Not yet provided" until a batch-specific document is on file. Our guide to reading a Certificate of Analysis explains what HPLC and mass-spectrometry results show.

References

  1. Khavinson VKh, Tarnovskaia SI, Lin'kova NS, et al. (2014). [Epigenetic aspects of peptidergic regulation of vascular endothelial cell proliferation during aging]. Adv Gerontol 27:108-14. PubMed 25051766
  2. Kozlov KL, Bolotov II, Linkova NS, et al. (2016). [Molecular aspects of vasoprotective peptide KED activity during atherosclerosis and restenosis]. Adv Gerontol 29:646-650. PubMed 28539025
  3. Chalisova NI, Lopatina NG, Kamishev NG, et al. (2012). Effect of tripeptide Lys-Glu-Asp on physiological activity of neuroimmunoendocrine system cells. Bull Exp Biol Med 153:569-72. PubMed 22977872 · DOI
  4. Khavinson VK, Lin'kova NS, Umnov RS (2021). Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease. Bull Exp Biol Med 171:190-193. PubMed 34173097 · DOI

Identity values are from PubChem (CID 87571363) and the cited papers; for linear peptides the mass was also checked against the sequence. Last updated 2026-11-19.

Related research peptides

From the research library